4//SEC Filing
Kassler-Taub Kenneth B. 4
Accession 0001127602-24-007621
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:29 PM ET
Size
15.7 KB
Accession
0001127602-24-007621
Insider Transaction Report
Form 4
Kassler-Taub Kenneth B.
SVP, Regulatory & QA
Transactions
- Exercise/Conversion
Common Stock
2024-02-28+27,556→ 154,268 total - Tax Payment
Common Stock
2024-02-28$2.62/sh−24,353$63,805→ 162,672 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−7,087→ 0 total→ Common Stock (7,087 underlying) - Exercise/Conversion
Common Stock
2024-02-28+7,087→ 126,712 total - Exercise/Conversion
Common Stock
2024-02-28+32,757→ 187,025 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−27,556→ 27,557 total→ Common Stock (27,556 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-28−32,757→ 65,513 total→ Common Stock (32,757 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001885219
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 4:29 PM ET
- Size
- 15.7 KB